AUTOTRANSFUSION IN MAN. A NEW RESEARCH METHOD FOR INVESTIGATING GASTRIC SECRETION.

AUTOTRANSFUSION IN MAN. A NEW RESEARCH METHOD FOR INVESTIGATING GASTRIC SECRETION. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

AUTOTRANSFUSION IN MAN. A NEW RESEARCH METHOD FOR INVESTIGATING GASTRIC SECRETION. Abstract Text:

AUTOTRANSFUSION IN MAN. A NEW RESEARCH METHOD FOR INVESTIGATING GASTRIC SECRETION. Publishing Authors By Initials

For similar biological sciences: physiology research abstracts see: biological sciences: physiology research

PUBMED ID PMID:

MEDLINE DATE:

AUTOTRANSFUSION IN MAN. A NEW RESEARCH METHOD FOR INVESTIGATING GASTRIC SECRETION. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Lancet

VOLUME: 2

Page Numbers: 271-2

Journal Abbreviation: Lancet

ISSN: 0140-6736

DAY: 7

MONTH: Aug

YEAR: 1965

AUTOTRANSFUSION IN MAN. A NEW RESEARCH METHOD FOR INVESTIGATING GASTRIC SECRETION. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985213

AUTOTRANSFUSION IN MAN. A NEW RESEARCH METHOD FOR INVESTIGATING GASTRIC SECRETION. Keywords Mesh Terms:

KEYWORDS: Physiology

MESH TERMS:

Chemical & Substance for Abstract: AUTOTRANSFUSION IN MAN. A NEW RESEARCH METHOD FOR INVESTIGATING GASTRIC SECRETION. Information

Substance Name: Gastrointestinal Hormones

Registry Number: 0

Grant and Affiliation Information for AUTOTRANSFUSION IN MAN. A NEW RESEARCH METHOD FOR INVESTIGATING GASTRIC SECRETION.

AFFILIATION:

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Lancet

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

AUTOTRANSFUSION IN MAN A NEW RESEARCH METHOD FOR INVESTIGATING GASTRIC SECRETION Related Publications

• A perspective on telmisartan and cardiovascular risk.
• Adverse childhood experiences and childhood autobiographical memory disturbance.
• Adverse childhood experiences and prescribed psychotropic medications in adults.
• Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressor.
• Assessing adaptive behaviour in the post-acute setting following traumatic brain injury: initial reliability and validity of the Adaptive Behaviour and Community Competency Scale (ABCCS).
• Bayesian inference for stochastic epidemic models with time-inhomogeneous removal rates.
• Blood pressure-the better biomarker: delay in clinical application.
• Brain stem gliomas: Patterns of Care in Victoria from 1998-2000.
• Cloretazine for the treatment of acute myeloid leukemia.
• Computational capabilities of recurrent NARX neural networks.
• Expression and regulation of anti-mullerian hormone in an oviparous species, the hen.
• Financial implications of plans to combat methicillin-resistant Staphylococcus aureus (MRSA) in an orthopaedic department.
• Hormone therapy and breast cancer: what factors modify the association?
• Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit.
• Is cancer risk associated with anger control and negative affect? Findings from a prospective cohort study.
• Learning long-term dependencies in NARX recurrent neural networks.
• Nelarabine activity in acute biphenotypic leukemia.
• Nicotine in blood in relation to smoking.
• Occupational exposure to ionizing and non-ionizing radiation and risk of glioma.
• On the distribution of performance from multiple neural-network trials.
• Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
• RECENT CASES OF DENTAL MALPRACTICE.
• Recurrent ectopic pregnancy.
• The cardiometabolic syndrome and calcium channel blocker combination drugs.
• The enduring effects of abuse and related adverse experiences in childhood : A convergence of evidence from neurobiology and epidemiology.
• The management of primary cutaneous melanoma in Victoria in 1996 and 2000.
• The oxygen effect on radiation-induced chromosome aberrations: breakage-versus-recombination hypotheses.
• The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels.
• The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2.
• Treatment of acute lymphoblastic leukaemia : a new era.